Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Celecoxib and cardiovascular risks.

Expert opinion on drug safety - 1 Nov 2005

Brophy James M

Abstract excerpt

In a very short time, COX-2 enzyme inhibitors have gone from the darlings to the pariahs of the pharmaceutical industry. These drugs were developed based on the hypothesis whereby selective inhibition of the COX enzyme would lead to reduction in pain and inflammation without associated gastrointestinal and bleeding risks. However, in September 2004, rofecoxib was voluntarily removed from the market for increased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Clinical Trials as Topic
Share to Cyclooxygenase Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Myocardial Infarction

Share to Pyrazoles

Share to Risk Factors

Share to Sulfonamides

Source

Identifiers

PMID: 16255660
DOI: 10.1517/14740338.4.6.1005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Celecoxib and cardiovascular risks.PMID 16255660Read ↗

Aspirin and coronary artery disease.Semantic proximity Read ↗

Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.Semantic proximity Read ↗

Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.Semantic proximity Read ↗

In vitro and in vivo molecular analysis of cyclooxygenase-2 (COX-2)-dependent and COX-2 independent cytoprotective pathways in the vascular endotheliumSemantic proximity Read ↗

Distinct functions of COX-1 and COX-2.Semantic proximity Read ↗

The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene.Semantic proximity Read ↗

Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib.Semantic proximity Read ↗

Disturbance of vision by COX-2 inhibitors.Semantic proximity Read ↗

Stroke and steroid hormonal contraception.Semantic proximity Read ↗

Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.